Read + Share
Seftel AD. Re: A Cost-Utility Analysis of Phosphodiesterase Type 5 Inhibitors in the
Treatment of Erectile Dysfunction. J Urol 2020 Sep 8:101097JU0000000000001252. doi: 10.1097/JU.0000000000001252.
PMID: 32897119
|
 |
|
Seftel AD. Re: A Cost-Utility Analysis of Phosphodiesterase Type 5 Inhibitors in the
Treatment of Erectile Dysfunction. J Urol 2020 Sep 8:101097JU0000000000001252. doi: 10.1097/JU.0000000000001252.
PMID: 32897119
|
|
|
|